Literature DB >> 4743921

Pigmented paravenous retino-choroidal atrophy. Helicoid retino-choriodal atrophy.

I A Chisholm, J Dudgeon.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4743921      PMCID: PMC1215093          DOI: 10.1136/bjo.57.8.584

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


× No keyword cloud information.
  3 in total

1.  [Contribution on chorioretinitis striata].

Authors:  G KRAFFEL
Journal:  Klin Monbl Augenheilkd Augenarztl Fortbild       Date:  1955

2.  RETINO-CHOROIDITIS RADIATA.

Authors:  T H Brown
Journal:  Br J Ophthalmol       Date:  1937-12       Impact factor: 4.638

3.  [Pigmented, paravenous retinal and chorioidal atrophy].

Authors:  P Amalric; U Schum
Journal:  Klin Monbl Augenheilkd       Date:  1968       Impact factor: 0.700

  3 in total
  7 in total

1.  ERG and EOG in progressive paravenous retinochoroidal atrophy.

Authors:  M R Lessel; A Thaler; P Heilig
Journal:  Doc Ophthalmol       Date:  1986-01-31       Impact factor: 2.379

2.  Connatal chorioretinal paravenous degeneration.

Authors:  N M Schweitzer
Journal:  Doc Ophthalmol       Date:  1982-01-29       Impact factor: 2.379

3.  Pigmented paravenous retinochoroidal atrophy (PPRA).

Authors:  F M Haustrate; J A Oosterhuis
Journal:  Doc Ophthalmol       Date:  1986-09-30       Impact factor: 2.379

4.  Bilateral macular coloboma and pigmented paravenous retinochoroidal atrophy.

Authors:  M S Chen; C H Yang; J S Huang
Journal:  Br J Ophthalmol       Date:  1992-04       Impact factor: 4.638

5.  Inflammatory pigmented paravenous retinochoroidal atrophy.

Authors:  K Yamaguchi; S Hara; Y Tanifuji; M Tamai
Journal:  Br J Ophthalmol       Date:  1989-06       Impact factor: 4.638

6.  Pigmented paravenous retinochoroidal atrophy: a nosologic entity?

Authors:  K Klop; M J van Schooneveld
Journal:  Doc Ophthalmol       Date:  1988 Oct-Nov       Impact factor: 2.379

7.  Pigmented paravenous retinochoroidal atrophy (Review).

Authors:  Hou-Bin Huang; Yi-Xin Zhang
Journal:  Exp Ther Med       Date:  2014-03-28       Impact factor: 2.447

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.